Home Newsfeeds JMP Securities Downgrades Minerva Neurosciences to Market Perform

JMP Securities Downgrades Minerva Neurosciences to Market Perform

JMP Securities analyst Jason Butler downgrades Minerva Neurosciences (NASDAQ:NERV) from Market Outperform to Market Perform.

October 17, 2022

1 minute read

JMP Securities analyst Jason Butler downgrades Minerva Neurosciences (NASDAQ:NERV) from Market Outperform to Market Perform.

Evercore ISI Group Downgrades Bath & Body Works to In-Line, Lowers Price Target to $28

July 13, 9:45 AM

Evercore ISI Group analyst Omar Saad downgrades Bath & Body Works (NYSE:BBWI) from Outperform to In-Line and lowers the price target from $60 to $28.

August 30, 11:44 PM

Tesla Inc (NASDAQ:TSLA) CEO Elon Musk on Wednesday said that version 12 of its full self-driving (FSD) software…

December 22, 8:33 AM

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.